The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

57.94 0.54 +0.94%
Market cap
$10.9B
P/E
19.8×
Fwd P/E
28.7×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a
Older periods Oct '25 Jan '26 Apr '26 Jul '26
P/E ratio

+8 more quarters

37.19 39.93 53.31 24.68
P/S ratio
3.40 3.80 2.90 3.29
P/FCF ratio
32.09 32.15 21.54 20.59
P/Operating CF
56.15 60.53 67.10 40.85
P/B ratio
1.69 1.89 1.49 1.68
EV/Sales
3.99 4.38 3.45 3.86
EV/EBITDA
15.39 16.58 16.53 17.61
EV/FCF
37.62 36.98 25.61 24.11
Current Ratio
1.89 1.34 1.27 1.22
Net Debt/EBITDA
10.03 7.70 36.05 7.55
Debt/Equity
0.30 0.30 0.30 0.31
Earnings Yield
2.69% 2.50% 1.88% 4.05%
Free Cash Flow Yield
3.12% 3.11% 4.64% 4.86%
Free Cash Flow per Share
0.75 0.81 0.49 1.41
Book value per Share
41.38 42.72 42.25 43.15
Free Cash Flow
149.90 158.70 96.40 273.00
EV/EBIT
23.89 25.45 29.30 30.04
Other line items

Show all line items

Columns are period end dates